Nyxoah Announces U.S. FDA Breakthrough Device Designation Granted for the Genio® System for Obstructive Sleep Apnea and Complete Concentric Collapse

Источник: Nasdaq GlobeNewswire / 14 сен 2021 01:00:00   America/Chicago